# The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients

> **NCT02338128** · — · COMPLETED · sponsor: **Shanghai 10th People's Hospital** · enrollment: 50 (actual)

## Conditions studied

- Disorders Associated With Peritoneal Dialysis
- Hyperuricemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02338128
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02338128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02338128, "The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02338128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*